Cargando…

Are Risk Factors Associated with Outcomes in Pancreatic Cancer?

BACKGROUND: The development of pancreatic cancer is a process in which genes interact with environmental factors. We performed this study to determine the effects of the ABO blood group, obesity, diabetes mellitus, metabolic syndrome (MetS), smoking, alcohol consumption and hepatitis B viral (HBV) i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, De-shen, Wang, Zhi-qiang, Zhang, Le, Qiu, Miao-zhen, Luo, Hui-yan, Ren, Chao, Zhang, Dong-sheng, Wang, Feng-hua, Li, Yu-hong, Xu, Rui-hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3404018/ https://www.ncbi.nlm.nih.gov/pubmed/22911869 http://dx.doi.org/10.1371/journal.pone.0041984

Ejemplares similares

The status of HBV infection influences metastatic pattern and survival in Chinese patients with pancreatic cancer
por: Wei, Xiao-li, et al.
Publicado: (2013)

Prognostic effects of 25-hydroxyvitamin D levels in gastric cancer
por: Ren, Chao, et al.
Publicado: (2012)

The Tumor-Log Odds of Positive Lymph Nodes-Metastasis Staging System, a Promising New Staging System for Gastric Cancer after D2 Resection in China
por: Qiu, Miao-zhen, et al.
Publicado: (2012)

Adjuvant Chemotherapy for Elderly Patients with Gastric Cancer after D2 Gastrectomy
por: Jin, Ying, et al.
Publicado: (2013)

A phase I study of toripalimab, an anti‐PD‐1 antibody, in patients with refractory malignant solid tumors
por: Wei, Xiao‐Li, et al.
Publicado: (2020)

Abnormal expression of paxillin correlates with tumor progression and poor survival in patients with gastric cancer
por: Chen, Dong-liang, et al.
Publicado: (2013)

S-1-Based Chemotherapy versus Capecitabine-Based Chemotherapy as First-Line Treatment for Advanced Gastric Carcinoma: A Meta-Analysis
por: He, Ming-ming, et al.
Publicado: (2013)

Primary small cell carcinoma of the esophagus: clinicopathological study of 44 cases
por: Chen, Wei-Wei, et al.
Publicado: (2014)

Phase II study of oxaliplatin combined with S-1 and leucovorin (SOL) for Chinese patients with metastatic colorectal cancer
por: Wang, Zhi-Qiang, et al.
Publicado: (2016)

The efficacy and safety of modified FOLFIRINOX as first-line chemotherapy for Chinese patients with metastatic pancreatic cancer
por: Wang, Zhi-Qiang, et al.
Publicado: (2019)

Overexpression of paxillin induced by miR-137 suppression promotes tumor progression and metastasis in colorectal cancer
por: Chen, Dong-Liang, et al.
Publicado: (2013)

Phase II clinical trial of S‐1 plus nanoparticle albumin‐bound paclitaxel in untreated patients with metastatic gastric cancer
por: He, Ming‐ming, et al.
Publicado: (2018)

A plasma cytokine and angiogenic factor (CAF) analysis for selection of bevacizumab therapy in patients with metastatic colorectal cancer
por: Bai, Long, et al.
Publicado: (2015)

Mutation profiling in chinese patients with metastatic colorectal cancer and its correlation with clinicopathological features and anti-EGFR treatment response
por: Li, Zhe-Zhen, et al.
Publicado: (2016)

Clinicopathological characteristics and prognostic analysis of Lauren classification in gastric adenocarcinoma in China
por: Qiu, Miao-zhen, et al.
Publicado: (2013)

Chemotherapy plus bevacizumab versus chemotherapy plus cetuximab as first-line treatment for patients with metastatic colorectal cancer: Results of a registry-based cohort analysis
por: Bai, Long, et al.
Publicado: (2016)

Copper-transporting P-type adenosine triphosphatase (ATP7A) is associated with platinum-resistance in non-small cell lung cancer (NSCLC)
por: Li, Zhuang-hua, et al.
Publicado: (2012)

Right- and left-sided colorectal cancers respond differently to cetuximab
por: Wang, Feng, et al.
Publicado: (2015)

A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio
por: Wei, Xiao-li, et al.
Publicado: (2015)

Regorafenib plus toripalimab in patients with metastatic colorectal cancer: a phase Ib/II clinical trial and gut microbiome analysis
por: Wang, Feng, et al.
Publicado: (2021)

Expert opinions on immunotherapy for patients with colorectal cancer
por: Wang, Feng, et al.
Publicado: (2020)

Prognostic value of preoperative serum lactate dehydrogenase levels for resectable gastric cancer and prognostic nomograms
por: Wang, Zi-Xian, et al.
Publicado: (2016)

Phase II trial of S-1 plus leucovorin in patients with advanced gastric cancer and clinical prediction by S-1 pharmacogenetic pathway
por: He, Ming-ming, et al.
Publicado: (2016)

Long non-coding RNA XIST regulates gastric cancer progression by acting as a molecular sponge of miR-101 to modulate EZH2 expression
por: Chen, Dong-liang, et al.
Publicado: (2016)

Correction to: Long non-coding RNA XIST regulates gastric cancer progression by acting as a molecular sponge of miR-101 to modulate EZH2 expression
por: Chen, Dong-liang, et al.
Publicado: (2021)

DNA polymeraseη protein expression predicts treatment response and survival of metastatic gastric adenocarcinoma patients treated with oxaliplatin-based chemotherapy
por: Teng, Kai-yuan, et al.
Publicado: (2010)

The Prognostic Value of Locoregional Interventions for BRAF V600E Metastatic Colorectal Cancer: A Retrospective Cohort Analysis
por: Ye, Liu-Fang, et al.
Publicado: (2021)

FcγRIIA and IIIA polymorphisms predict clinical outcome of trastuzumab-treated metastatic gastric cancer
por: Wang, De-shen, et al.
Publicado: (2017)

The clinicopathologic relevance and prognostic value of tumor deposits and the applicability of N1c category in rectal cancer with preoperative radiotherapy
por: Wei, Xiao-li, et al.
Publicado: (2016)

Patients with Old Age or Proximal Tumors Benefit from Metabolic Syndrome in Early Stage Gastric Cancer
por: Wei, Xiao-li, et al.
Publicado: (2014)

Optimizing Chemotherapy of Pancreatic Acinar Cell Carcinoma: Our Experiences and Pooled Analysis of Literature
por: Xu, Jian-Ying, et al.
Publicado: (2022)

Effect of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Women: A Randomized Clinical Trial
por: Wang, De-Shen, et al.
Publicado: (2021)

Prognostic relevance of melanoma antigen D1 expression in colorectal carcinoma
por: Zeng, Zhao-lei, et al.
Publicado: (2012)

A two-microRNA-based signature predicts first-line chemotherapy outcomes in advanced colorectal cancer patients
por: Lu, Jia-huan, et al.
Publicado: (2018)

Detection of carcinoembryonic antigen messenger RNA in blood using quantitative real-time reverse transcriptase-polymerase chain reaction to predict recurrence of gastric adenocarcinoma
por: Qiu, Miao-zhen, et al.
Publicado: (2010)

Low preoperative albumin-globulin score predicts favorable survival in esophageal squamous cell carcinoma
por: Zhang, Fei, et al.
Publicado: (2016)

Safety and Clinical Activity of SHR7390 Monotherapy or Combined With Camrelizumab for Advanced Solid Tumor: Results From Two Phase I Trials
por: Wei, Xiao-Li, et al.
Publicado: (2022)

The Role of Non-Curative Surgery in Incurable, Asymptomatic Advanced Gastric Cancer
por: He, Ming-ming, et al.
Publicado: (2013)

Green Tea Consumption and Risk of Pancreatic Cancer: A Meta-analysis
por: Zeng, Jin-Long, et al.
Publicado: (2014)

First-in-human phase Ia study of the PI3Kα inhibitor CYH33 in patients with solid tumors
por: Wei, Xiao-Li, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f9l4362nej7sfnqh5mt76fpuhd